Simoncini, T <br/><br/>
Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors.  [electronic resource] 

 -  Human reproduction (Oxford, England)  Aug 2007 
 - 2325-34 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-1161 
<br/><br/><label>Standard No.: </label>10.1093/humrep/dem109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldosterone--pharmacology<br/>Androstadienes--pharmacology<br/>Androstenes--pharmacology<br/>Cells, Cultured<br/>Endothelium, Vascular--cytology<br/>Enzyme Activation<br/>Estradiol--pharmacology<br/>Flavonoids--pharmacology<br/>Humans<br/>Medroxyprogesterone Acetate--pharmacology<br/>Mifepristone--pharmacology<br/>Nitric Oxide--biosynthesis<br/>Nitric Oxide Synthase Type III--drug effects<br/>Progesterone--pharmacology<br/>Receptors, Mineralocorticoid--drug effects<br/>Receptors, Progesterone--drug effects<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Wortmannin